Conference Reports for NATAP

EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom  April 9-13 Back

RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/r/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION       Reported by Jules Levin EASL 2014 April 9-13 London, UK   Paul Kwo, Parvez Mantry, Eoin Coakley, Helen Te, Hugo Vargas, Robert Brown, Jr., Fredric Gordon, Josh Levitsky, Norah Terrault, James Burton, Jr., Wangang Xie, Carolyn Setze, Prajakta Badri, Regis A. Vilchez, Xavier Forns